Condition
Colorectal Cancer Liver Metastasis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Colorectal Cancer Liver Metastasis clinical trials that are recruiting, in China. By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest Colorectal Cancer Liver Metastasis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AI model to predict risk of liver spread after colorectal cancer surgery | — | Wuhan, Hubei | Recruiting | Feb 6, 2026 |
| Multimodal Thermal Therapy for Malignant Liver Tumors | — | Shanghai, Shanghai Municipality | Recruiting | Sep 8, 2025 |
| Fecal transplant plus QL1706, bevacizumab, and XELOX as first-line treatment for advanced MSS colon cancer with liver metastases | Phase 2 | Changzhou | Recruiting | Jan 30, 2025 |
| PULSAR combined with PD-1 antibody, chemotherapy, and bevacizumab for colorectal cancer that has spread to the liver | Phase 2 | Fuzhou, Fujian | Recruiting | Jan 23, 2025 |
| Treatment for colorectal cancer liver metastasis using combined therapies | Phase 2 | Shanghai | Recruiting | Sep 19, 2024 |
All recruiting trials (5)
-
AI model to predict risk of liver spread after colorectal cancer surgery
This project will test whether an AI model using preoperative CT scans, postoperative pathology images, and routine clinical data can predict the risk of liver metastasis within two years for people having curative surgery for stage I–III colorectal cancer.
-
Multimodal Thermal Therapy for Malignant Liver Tumors
This study tests a combined cryo- and heat-based therapy to see if it can help people with liver cancers live longer and have fewer tumors.
-
Fecal transplant plus QL1706, bevacizumab, and XELOX as first-line treatment for advanced MSS colon cancer with liver metastases
This trial will test whether giving a fecal microbiota transplant before combined QL1706, bevacizumab, and XELOX chemotherapy helps adults with untreated advanced MSS colon cancer that has spread to the liver.
-
PULSAR combined with PD-1 antibody, chemotherapy, and bevacizumab for colorectal cancer that has spread to the liver
This trial tests if adding PULSAR radiotherapy to a regimen with a PD-1 blocker, standard chemotherapy, and bevacizumab helps people with colorectal cancer liver metastases live longer without their disease getting worse.
-
Treatment for colorectal cancer liver metastasis using combined therapies
This study is testing a new treatment combining a special procedure and medication for people with colorectal cancer that has spread to the liver and hasn't responded to earlier treatments.
Related topics
Quick answers
How many Colorectal Cancer Liver Metastasis clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.